BIOMAT Database Logo BIOMAT Database Logo

NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. 2023

Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Research Group Biomarkers for Infectious Diseases, TWINCORE Centre for Experimental and Clinical Infection Research, Hannover, Germany.

In addition to antioxidative and anti-inflammatory properties, activators of the cytoprotective nuclear factor erythroid-2-like-2 (NRF2) signaling pathway have antiviral effects, but the underlying antiviral mechanisms are incompletely understood. We evaluated the ability of the NRF2 activators 4-octyl itaconate (4OI), bardoxolone methyl (BARD), sulforaphane (SFN), and the inhibitor of exportin-1 (XPO1)-mediated nuclear export selinexor (SEL) to interfere with influenza virus A/Puerto Rico/8/1934 (H1N1) infection of human cells. All compounds reduced viral titers in supernatants from A549 cells and vascular endothelial cells in the order of efficacy SEL>4OI>BARD = SFN, which correlated with their ability to prevent nucleo-cytoplasmic export of viral nucleoprotein and the host cell protein p53. In contrast, intracellular levels of viral HA mRNA and nucleocapsid protein (NP) were unaffected. Knocking down mRNA encoding KEAP1 (the main inhibitor of NRF2) or inactivating the NFE2L2 gene (which encodes NRF2) revealed that physiologic NRF2 signaling restricts IAV replication. However, the antiviral effect of all compounds was NRF2-independent. Instead, XPO1 knock-down greatly reduced viral titers, and incubation of Calu3 cells with an alkynated 4OI probe demonstrated formation of a covalent complex with XPO1. Ligand-target modelling predicted covalent binding of all three NRF2 activators and SEL to the active site of XPO1 involving the critical Cys528. SEL and 4OI manifested the highest binding energies, whereby the 4-octyl tail of 4OI interacted extensively with the hydrophobic groove of XPO1, which binds nuclear export sequences on cargo proteins. Conversely, SEL as well as the three NRF2 activators were predicted to covalently bind the functionally critical Cys151 in KEAP1. Blocking XPO1-mediated nuclear export may, thus, constitute a "noncanonical" mechanism of anti-influenza activity of electrophilic NRF2 activators that can interact with similar cysteine environments at the active sites of XPO1 and KEAP1. Considering the importance of XPO1 function to a variety of pathogenic viruses, compounds that are optimized to inhibit both targets may constitute an important class of broadly active host-directed treatments that embody anti-inflammatory, cytoprotective, and antiviral properties.

UI MeSH Term Description Entries
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072019 Kelch-Like ECH-Associated Protein 1 An adaptor protein characterized by an N-terminal BTB-POZ DOMAIN and six KELCH REPEATS that functions as a substrate for the E3 UBIQUITIN LIGASE complex. It negatively-regulates NF-E2-RELATED FACTOR 2 by targeting it for ubiquitination and degradation by the PROTEASOME. It also represses genes regulated by ANTIOXIDANT RESPONSE ELEMENTS. KEAP-1 Protein,KEAP1 Protein,KEAP 1 Protein,Kelch Like ECH Associated Protein 1
D012261 Ribonucleoproteins Complexes of RNA-binding proteins with ribonucleic acids (RNA). Ribonucleoprotein
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D042783 Endothelial Cells Highly specialized EPITHELIAL CELLS that line the HEART; BLOOD VESSELS; and lymph vessels, forming the ENDOTHELIUM. They are polygonal in shape and joined together by TIGHT JUNCTIONS. The tight junctions allow for variable permeability to specific macromolecules that are transported across the endothelial layer. Capillary Endothelial Cells,Lymphatic Endothelial Cells,Vascular Endothelial Cells,Capillary Endothelial Cell,Cell, Capillary Endothelial,Cell, Endothelial,Cell, Lymphatic Endothelial,Cell, Vascular Endothelial,Cells, Capillary Endothelial,Cells, Endothelial,Cells, Lymphatic Endothelial,Cells, Vascular Endothelial,Endothelial Cell,Endothelial Cell, Capillary,Endothelial Cell, Lymphatic,Endothelial Cell, Vascular,Endothelial Cells, Capillary,Endothelial Cells, Lymphatic,Endothelial Cells, Vascular,Lymphatic Endothelial Cell,Vascular Endothelial Cell
D051267 NF-E2-Related Factor 2 A basic-leucine zipper transcription factor that was originally described as a transcriptional regulator controlling expression of the BETA-GLOBIN gene. It may regulate the expression of a wide variety of genes that play a role in protecting cells from oxidative damage. Nfe2l2 Protein,Nuclear Factor (Erythroid-Derived 2)-Like 2 Protein,Nuclear Factor E2-Related Factor 2,NF E2 Related Factor 2,Nuclear Factor E2 Related Factor 2
D053118 Influenza A Virus, H1N1 Subtype A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918 and 2009 H1N1 pandemic. H1N1 Influenza Virus,H1N1 Virus,H1N1 subtype,H1N1v Viruses,Influenza A (H1N1)pdm09,Influenza A (H1N1)pdm09 Virus,Influenza A H1N1, Variant Virus,Swine-Origin Influenza A H1N1 Virus,H1N1 Influenza Viruses,H1N1 Viruses,H1N1 subtypes,H1N1v Virus,Influenza Virus, H1N1,Swine Origin Influenza A H1N1 Virus,Virus, H1N1,Virus, H1N1 Influenza,Virus, H1N1v,subtype, H1N1
D021581 Active Transport, Cell Nucleus Gated transport mechanisms by which proteins or RNA are moved across the NUCLEAR MEMBRANE. Nuclear Export,Nuclear Import,Nuclear Transport,Nucleocytoplasmic Transport,Nucleo-cytoplasmic Transport,Export, Nuclear,Import, Nuclear,Nucleo cytoplasmic Transport,Transport, Nuclear,Transport, Nucleo-cytoplasmic,Transport, Nucleocytoplasmic,Transports, Nucleo-cytoplasmic

Related Publications

Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Cytoplasmic and nucleoplasmic viral RNPs in influenza virus-infected MDCK cells.
October 1972, Virology,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Cytoplasmic and nuclear input virus RNPs in influenza virus-infected cells.
December 1979, The Journal of general virology,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.
January 1999, Journal of virology,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Tryptophan Trimers and Tetramers Inhibit Dengue and Zika Virus Replication by Interfering with Viral Attachment Processes.
February 2020, Antimicrobial agents and chemotherapy,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis.
May 2020, PLoS neglected tropical diseases,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
February 2013, The FEBS journal,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Polypeptides inhibit HIV-1 replication by interfering viral Vpu-mediated tetherin degradation.
September 2023, Infectious medicine,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Nucleo-cytoplasmic studies in the development of influenza virus in mammaliam cells.
January 1969, Archiv fur die gesamte Virusforschung,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription.
March 2009, The international journal of biochemistry & cell biology,
Fakhar H Waqas, and Mahmoud Shehata, and Walid A M Elgaher, and Antoine Lacour, and Naziia Kurmasheva, and Fabio Begnini, and Anders E Kiib, and Julia Dahlmann, and Chutao Chen, and Andreas Pavlou, and Thomas B Poulsen, and Sylvia Merkert, and Ulrich Martin, and Ruth Olmer, and David Olagnier, and Anna K H Hirsch, and Stephan Pleschka, and Frank Pessler
Emodin and rhapontigenin inhibit the replication of African swine fever virus by interfering with virus entry.
September 2023, Veterinary microbiology,
Copied contents to your clipboard!